chr1-50421001-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032110.3(DMRTA2):c.536G>A(p.Gly179Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,504,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 2AN: 100062Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 56068
GnomAD4 exome AF: 0.0000103 AC: 14AN: 1352794Hom.: 0 Cov.: 31 AF XY: 0.0000105 AC XY: 7AN XY: 666864
GnomAD4 genome AF: 0.000105 AC: 16AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.536G>A (p.G179E) alteration is located in exon 2 (coding exon 1) of the DMRTA2 gene. This alteration results from a G to A substitution at nucleotide position 536, causing the glycine (G) at amino acid position 179 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at